Interventional cardiologists at the University of Ottawa Heart Institute are championing broad-based innovation by using catheter-based procedures to treat a variety of conditions. This gallery highlights a minimally invasive procedure, called TAVI (transcatheter aortic valve implantation), for
Heart failure is a disease that challenges the patient and the health care system alike. An often progressive condition with many potential causes and no cure, it can be effectively managed. Doing so is a complex effort that requires diligence and careful monitoring, but a recent study evaluating
Participants at the University of Ottawa Heart Institute’s 25th Annual Research Day attend a research presentation. The program included more than 75 presentations in the categories of basic science, clinical science, and allied and population health. May 7, 2012, marked the 25th Annual Research Day
RAPID GENE, the first-ever bedside genetic test, has received peer-reviewed validation in The Lancet, the world’s leading general medical journal. As first reported in The Beat (Volume 7, Issue 1), RAPID GENE is a point-of-care genetic test that uses a simple cheek swab to assess whether a patient
Family medicine is an important setting for managing cardiovascular risk factors and preventing the onset of heart disease, as well as managing risk factors following a cardiac event. If a patient is a smoker, explained Dr. Andrew Pipe, Chief of Prevention and Rehabilitation at the University of
In March, Dr. Rob Beanlands was appointed Chief of Cardiology at the University of Ottawa Heart Institute. He brings extensive career experience in cardiovascular imaging and a passion for patient-centred care and education to his new position. Dr. Beanlands takes over from Dr. Terrence Ruddy, Chief